13 May 2022 | News
In the form of clinical entrepreneur pilot programme and targeted training
Image credit: shutterstock
The University of Western Australia (UWA) and partners will deliver a clinical entrepreneur pilot programme and targeted training to boost medical product commercialisation, both funded by the MTPConnect Researcher Exchange and Development within Industry programme.
MTPConnect, an organisation created to accelerate the rate of growth of the medical technology, biotechnology and pharmaceutical sector in Australia, has announced the initiatives.
Professor Kevin Pfleger, Director Biomedical Innovation at UWA, said the entrepreneur programme will help equip healthcare professionals with the skills to translate and commercialise their ideas and innovation into impactful solutions.
The programme will provide workshops and networking opportunities to healthcare professionals to develop innovative ideas into products, enterprises and businesses that benefit the clinical care of patients.
Wrays, one of the largest independent intellectual property specialist firms in Australia, has partnered with Yuuwa Capital, QRC Solutions and Biodesign Australia, administered by UWA.
The Wrays Consortium will deliver The Commercialisation Framework Supporting Biomedical Outcomes, providing training and education programmes to develop the skill sets required for the commercialisation of therapeutic products and medical technologies.